| Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index S Taheri, L Lin, D Austin, T Young, E Mignot PLoS medicine 1 (3), e62, 2004 | 3418 | 2004 |
| The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene L Lin, J Faraco, R Li, H Kadotani, W Rogers, X Lin, X Qiu, PJ de Jong, ... Cell 98 (3), 365-376, 1999 | 3094 | 1999 |
| A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains C Peyron, J Faraco, W Rogers, B Ripley, S Overeem, Y Charnay, ... Nature medicine 6 (9), 991-997, 2000 | 2429 | 2000 |
| Hypocretin (orexin) deficiency in human narcolepsy S Nishino, B Ripley, S Overeem, GJ Lammers, E Mignot The Lancet 355 (9197), 39-40, 2000 | 2103 | 2000 |
| The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias E Mignot, GJ Lammers, B Ripley, M Okun, S Nevsimalova, S Overeem, ... Archives of neurology 59 (10), 1553-1562, 2002 | 1320 | 2002 |
| The NASA Twins Study: A multidimensional analysis of a year-long human spaceflight FE Garrett-Bakelman, M Darshi, SJ Green, RC Gur, L Lin, BR Macias, ... Science 364 (6436), eaau8650, 2019 | 919 | 2019 |
| Narcolepsy with cataplexy Y Dauvilliers, I Arnulf, E Mignot The Lancet 369 (9560), 499-511, 2007 | 900 | 2007 |
| Dopaminergic role in stimulant-induced wakefulness JP Wisor, S Nishino, I Sora, GH Uhl, E Mignot, DM Edgar Journal of Neuroscience 21 (5), 1787-1794, 2001 | 893 | 2001 |
| A CLOCK Polymorphism Associated with Human Diurnal Preference D Katzenberg, T Young, L Finn, L Lin, DP King, JS Takahashi, E Mignot Sleep 21 (6), 569-576, 1998 | 753 | 1998 |
| Genetic and familial aspects of narcolepsy E Mignot Neurology 50 (2_suppl_1), S16-S22, 1998 | 752 | 1998 |
| Complex HLA-DR and-DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups E Mignot, L Lin, W Rogers, Y Honda, X Qiu, X Lin, M Okun, H Hohjoh, ... The American Journal of Human Genetics 68 (3), 686-699, 2001 | 699 | 2001 |
| Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China F Han, L Lin, SC Warby, J Faraco, J Li, SX Dong, P An, L Zhao, LH Wang, ... Annals of neurology 70 (3), 410-417, 2011 | 566 | 2011 |
| Narcolepsy is strongly associated with the T-cell receptor alpha locus J Hallmayer, J Faraco, L Lin, S Hesselson, J Winkelmann, M Kawashima, ... Nature genetics 41 (6), 708-711, 2009 | 554 | 2009 |
| Slow wave sleep disruption increases cerebrospinal fluid amyloid-β levels YES Ju, SJ Ooms, C Sutphen, SL Macauley, MA Zangrilli, G Jerome, ... Brain 140 (8), 2104-2111, 2017 | 550 | 2017 |
| Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy S Nishino, B Ripley, S Overeem, S Nevsimalova, GJ Lammers, J Vankova, ... Annals of Neurology: Official Journal of the American Neurological …, 2001 | 540 | 2001 |
| HLA DQB1* 0602 is associated with cataplexy in 509 narcoleptic patients E Mignot, R Hayduk, J Black, FC Grumet, C Guilleminault Sleep 20 (11), 1012-1020, 1997 | 516 | 1997 |
| Pharmacological aspects of human and canine narcolepsy S Nishino, E Mignot Progress in neurobiology 52 (1), 27-78, 1997 | 511 | 1997 |
| Fluctuation of extracellular hypocretin‐1 (orexin A) levels in the rat in relation to the light–dark cycle and sleep–wake activities Y Yoshida, N Fujiki, T Nakajima, B Ripley, H Matsumura, H Yoneda, ... European Journal of Neuroscience 14 (7), 1075-1081, 2001 | 501 | 2001 |
| CSF hypocretin/orexin levels in narcolepsy and other neurological conditions B Ripley, S Overeem, N Fujiki, S Nevsimalova, M Uchino, J Yesavage, ... Neurology 57 (12), 2253-2258, 2001 | 495 | 2001 |
| Sleeping with the hypothalamus: emerging therapeutic targets for sleep disorders E Mignot, S Taheri, S Nishino Nature neuroscience 5 (Suppl 11), 1071-1075, 2002 | 494 | 2002 |
